Stephanie Parker, BA
Stephanie Parker, BA
Research Coordinator
University of Washington
850 Republican St
Box 358050
Seattle,
WA
USA
98109
Papers:
74 - Focused Plenary
A phase I trial of a DNA plasmid-based vaccine targeting insulin-like growth factor binding protein-2 (IGFBP-2) in patients with advanced ovarian cancer: preliminary safety and immunogenicity